85
Participants
Start Date
June 30, 2006
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
Pasireotide
Novartis Investigative Site, Brussels
Novartis Investigative Site, Leuven
Novartis Investigative Site, Liège
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1), Tampa
Novartis Investigative Site, Essen
Novartis Investigative Site, München
Cedars Sinai Medical Center SC - 4, Los Angeles
Stanford University Medical Center Stanford Cancer Center (3), Stanford
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology, Houston
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Oslo
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY